Skip to main content

Table 2 Rapid clinical remission of participants following lenalidomide therapy

From: Efficacy and safety of lenalidomide in HIV-associated cryptococcal meningitis patients with persistent intracranial inflammation: an open-label, single-arm, prospective interventional study

Week

0

4

8

12

24

Fever, number (%)

4 (28.6)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Headache, number (%)

7 (50.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Altered mentation number (%)

4 (28.6)

1 (7.1)

1 (7.1)

0 (0.0)

0 (0.0)

Seizures, number (%)

2 (14.3)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)